Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 3Nausea 3Gastrointestinal Neoplasms 1

Interventions

Dexamethasone 29Aprepitant 24Palonosetron 20Ondansetron 20Calcium Dobesilate 13Olanzapine 12Granisetron 11Therapeutics 7fosaprepitant 6Doxorubicin 6Cyclophosphamide 6dexamethasone acetate 5netupitant 4Vincristine 4dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Metoclopramide 3Lorazepam 3Dronabinol 3Acupressure 3peppermint oil 2netupitant, palosentron drug combination 2ginger extract 2dexamethasone 21-phosphate 2Sugars 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Nausea × dolasetron × Clear all
NCT02550119 2017-03-28

Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy

University of Southern California

Phase NA Terminated
19 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Nausea, Vomiting

NCT00003817 2015-10-15

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

University of Rochester

Phase 2 Completed
700 enrolled

Nausea, Vomiting

NCT00020657 2015-10-15

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

University of Rochester

Phase 3 Completed

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡